Designing A Measurable, Outcome-Driven Value-Based Care Model: The Community Health Network (MyCHN) Case Study is starting in

Medication-Assisted Treatment

Medication-assisted treatment (MAT) is a treatment for substance use disorders that combines medication with behavioral therapies

Executive Briefing | Dec 20, 2024
Medication-assisted treatment (MAT) for opioid use disorder (OUD) has been referred to as the “gold standard” (see Facing Addiction In America: The Surgeon General’s Spotlight On Opioids) for treatment. But that endorsement hasn’t been enough to drive the adoption of MAT. Health and human service (HHS) executives—at the policy and practice level—are trying to drive the use…
Sponsored Content
Greg Ganse, Chief Executive Officer, Altruix, & Monica E. Oss, Chief Executive Officer, OPEN MINDS, discuss the strategic and operational considerations for implementing long-acting injectables (LAIs) in behavioral health settings, and what it takes to turn clinical intent into scalable action. In this session, Greg Ganse, CEO of Altruix, joins OPEN MINDS CEO Monica Oss…
Altruix is a behavioral health pharmacy dedicated to individuals with serious and persistent mental illness and intellectual & developmental disabilities. Altruix pharmacies serve this population through high-touch relationships with community-based behavioral health agencies, group homes, and other care providers.